Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Vukovic, Petar (35584122100)"

Filter results by typing the first few letters
Now showing 1 - 10 of 10
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    A rare case of pacemaker lead endocarditis successfully treated with open heart surgery
    (2019)
    Boljevic, Darko (57204930789)
    ;
    Barac, Aleksandra (55550748700)
    ;
    Vukovic, Petar (35584122100)
    ;
    Kojic, Dejan (57211564921)
    ;
    Bojic, Milovan (7005865489)
    ;
    Micic, Jelena (7005054108)
    ;
    Rubino, Salvatore (55240504800)
    ;
    Paglietti, Bianca (7801351059)
    ;
    Nikolic, Aleksandra (59432908700)
    Background: Cardiac device-related endocarditis has emerged as a serious complication in the era of advanced medical technology. Pacemaker related infections are rare and life-threatening with incidence from 0.06% to 7% and high mortality rate (30-35%). Diagnosis is hard, frequently delayed and could be even missed due to poor clinical findings. The average delay in diagnosis is 5.5 month. We report a case of the late-onset of pacemaker lead endocarditis caused by S. epidermidis successfully treated with open heart surgery. Case Report: Patient with persistent high fever for 11 month and suspicion for infective endocarditis was admitted in Cardiovascular Institute. No clinical signs of endocarditis were observed. TTE revealed large vegetation 30 × 17 mm attached to the atrial electrodes with high embolic potential. This finding was verified by transesophageal echocardiography (TEE), although CT scan did not reveal vegetation. Blood cultures were negative. A sternotomy with cardiopulmonary bypass was performed and electrodes were extracted with large vegetation. Intraoperative finding revealed large thrombus with vegetation around pacemaker leads. Cultures of the electrodes and vegetation revealed Staphylococcus epidermidis. Surgery was followed up with antibiotic treatment for 6 weeks. He has been followed up for the next 2 years, and without complications. Conclusion: The absence of criteria for endocarditis and negative blood cultures should not keep the physician from ruling out lead endocarditis. This complication carries high risk of mortality if left untreated. © 2019 Boljevic et al.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    A rare case of pacemaker lead endocarditis successfully treated with open heart surgery
    (2019)
    Boljevic, Darko (57204930789)
    ;
    Barac, Aleksandra (55550748700)
    ;
    Vukovic, Petar (35584122100)
    ;
    Kojic, Dejan (57211564921)
    ;
    Bojic, Milovan (7005865489)
    ;
    Micic, Jelena (7005054108)
    ;
    Rubino, Salvatore (55240504800)
    ;
    Paglietti, Bianca (7801351059)
    ;
    Nikolic, Aleksandra (59432908700)
    Background: Cardiac device-related endocarditis has emerged as a serious complication in the era of advanced medical technology. Pacemaker related infections are rare and life-threatening with incidence from 0.06% to 7% and high mortality rate (30-35%). Diagnosis is hard, frequently delayed and could be even missed due to poor clinical findings. The average delay in diagnosis is 5.5 month. We report a case of the late-onset of pacemaker lead endocarditis caused by S. epidermidis successfully treated with open heart surgery. Case Report: Patient with persistent high fever for 11 month and suspicion for infective endocarditis was admitted in Cardiovascular Institute. No clinical signs of endocarditis were observed. TTE revealed large vegetation 30 × 17 mm attached to the atrial electrodes with high embolic potential. This finding was verified by transesophageal echocardiography (TEE), although CT scan did not reveal vegetation. Blood cultures were negative. A sternotomy with cardiopulmonary bypass was performed and electrodes were extracted with large vegetation. Intraoperative finding revealed large thrombus with vegetation around pacemaker leads. Cultures of the electrodes and vegetation revealed Staphylococcus epidermidis. Surgery was followed up with antibiotic treatment for 6 weeks. He has been followed up for the next 2 years, and without complications. Conclusion: The absence of criteria for endocarditis and negative blood cultures should not keep the physician from ruling out lead endocarditis. This complication carries high risk of mortality if left untreated. © 2019 Boljevic et al.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Cardio-microcurrent device for chronic heart failure: first-in-human clinical study
    (2021)
    Kosevic, Dragana (15071017200)
    ;
    Wiedemann, Dominik (26639916000)
    ;
    Vukovic, Petar (35584122100)
    ;
    Ristic, Velibor (35491539000)
    ;
    Riebandt, Julia (55840122100)
    ;
    Radak, Una (57221966988)
    ;
    Brandes, Kersten (7003943088)
    ;
    Goettel, Peter (57203765875)
    ;
    Duengen, Hans-Dirk (35332227300)
    ;
    Tahirovic, Elvis (24339336300)
    ;
    Kottmann, Tatjana (57189696360)
    ;
    Voss, Hans Werner (57225324802)
    ;
    Zdravkovic, Marija (24924016800)
    ;
    Putnik, Svetozar (16550571800)
    ;
    Schmitto, Jan D. (57219444826)
    ;
    Mueller, Johannes (7404870968)
    ;
    Rame, Jesus Eduardo (6603350865)
    ;
    Peric, Miodrag (7006618529)
    Aims: Most devices for treating ambulatory Class II and III heart failure are linked to electrical pulses. However, a steady electric potential gradient is also necessary for appropriate myocardial performance and may be disturbed by structural heart diseases. We investigated whether chronic application of electrical microcurrent to the heart is feasible and safe and improves cardiac performance. The results of this study should provide guidance for the design of a two-arm, randomized, controlled Phase II trial. Methods and results: This single-arm, non-randomized pilot study involved 10 patients (9 men; mean age, 62 ± 12 years) at two sites with 6 month follow-up. All patients had New York Heart Association (NYHA) Class III heart failure and non-ischaemic dilated cardiomyopathy, with left ventricular ejection fraction (LVEF) <35%. A device was surgically placed to deliver a constant microcurrent to the heart. The following tests were performed at baseline, at hospital discharge, and at six time points during follow-up: determination of LVEF and left ventricular end-diastolic/end-systolic diameter by echocardiography; the 6 min walk test; and assessment of NYHA classification and quality of life (36-Item Short-Form Health Survey questionnaire). Microcurrent application was feasible and safe; no device-related or treatment-related adverse events occurred. During follow-up, rapid and significant signal of efficacy (P < 0.005) was present with improvements in LVEF, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, and distance walked. For eight patients, NYHA classification improved from Class III to Class I (for seven, as early as 14 days post-operatively); for one, to Class II; and for one, to Class II/III. 36-Item Short-Form Health Survey questionnaire scores also improved highly significantly. Conclusions: Chronic application of microcurrent to the heart is feasible and safe and leads to a rapid and lasting improvement in heart function and a near normalization of heart size within days. The NYHA classification and quality of life improve just as rapidly. © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Midterm Results After Simultaneous Carotid Artery Stenting and Cardiac Surgery
    (2020)
    Zivkovic, Igor (57192104502)
    ;
    Vukovic, Petar (35584122100)
    ;
    Milacic, Petar (24832086700)
    ;
    Milicic, Miroslav (22934854000)
    ;
    Sagic, Dragan (35549772400)
    ;
    Ilijevski, Nenad (57209017323)
    ;
    Krasic, Stasa (57192096021)
    ;
    Peric, Miodrag (7006618529)
    ;
    Micovic, Slobodan (25929461500)
    Background: The presence of carotid artery disease is known risk factor for perioperative stroke in cardiac surgery. The optimal management of patients with concomitant heart and carotid artery disease is not known. Simultaneous or staged carotid endarterectomy has been proposed to prevent stroke. In an attempt to reduce perioperative morbidity and death, simultaneous carotid stenting and cardiac surgery were implemented (hybrid procedure). This study evaluated early and midterm results after the hybrid procedure. Methods: From November 2012 through November 2018, 54 patients (36 men; an average age, 65.8 ± 7.3 years) underwent the hybrid procedure. The primary end points were the occurrence of perioperative cerebral stroke, transient ischemic attack (TIA), acute myocardial infarction, bleeding, or death. The mean follow-up period was 30 months. Results: The 30-day mortality was 0%. Periprocedural incidence of stroke and transient ischemic attack were 1.9% and 7.6%, respectively, and acute myocardial infarction occurred in 1 patient (1.9%). No patients required repeat thoracotomy for bleeding. Four patients (7.6%) died during follow-up. The cause of death was stroke in 2 patients (3.8%), heart failure in 1 (1.9%), and multiorgan failure in 1 (1.9%). In-stent restenosis of the carotid artery occurred in 1 patient (1.9%). Conclusions: In this small group of patients, the hybrid procedure proved to be a safe and efficient treatment for patients with concomitant carotid and cardiac diseases. The low rate of perioperative complications and good midterm results are encouraging. © 2020 The Society of Thoracic Surgeons
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Right anterior thoracotomy vs. upper hemisternotomy for aortic valve replacement with Perceval S: is there a difference?
    (2024)
    Okiljevic, Bogdan (57193093252)
    ;
    Raickovic, Tatjana (57217308817)
    ;
    Zivkovic, Igor (57192104502)
    ;
    Vukovic, Petar (35584122100)
    ;
    Milicic, Miroslav (22934854000)
    ;
    Stojanovic, Ivan (55014093700)
    ;
    Milacic, Petar (24832086700)
    ;
    Micovic, Slobodan (25929461500)
    Background: Our study aimed to evaluate the early outcomes of aortic valve replacement with Perceval S sutureless valve through the right anterior thoracotomy and upper hemisternotomy approaches, and to determine if there are any differences between these two approaches. Methods: We carried out a study using data from 174 patients who underwent minimally invasive Perceval S valve implantation for aortic valve stenosis between January 2018 and August 2023. This was a retrospective, single-center observational study. The patients were divided into two groups: the hemisternotomy group (n = 100) and the right anterior thoracotomy group (n = 74). Results: The overall in-hospital mortality was 1,7%. The cardiopulmonary bypass and cross-clamp times were longer in the right anterior thoracotomy group (p <.001). There were no statistically significant differences in terms of stroke, paravalvular leak, mechanical ventilation time, blood transfusion requirements, pacemaker implantation, reexploration for bleeding, conversion, wound infection, or in-hospital stay. Postoperative chest drainage was lower (p <.001) and postoperative atrial fibrillation occurred less frequently (p =.044) in the right anterior thoracotomy group. The median intensive care unit stay was shorter in the right anterior thoracotomy group (p =.018). Conclusion: Aortic valve replacement with the Perceval S valve through either an upper hemisternotomy or a right anterior thoracotomy is a procedure associated with low perioperative complication rates. Right anterior thoracotomy for an aortic valve replacement with the Perceval S valve was associated with lower postoperative bleeding, a lower postoperative atrial fibrillation incidence and a shorter intensive care unit stay compared to upper hemistornotomy. 2024 Okiljevic, Raickovic, Zivkovic, Vukovic, Milicic, Stojanovic, Milacic and Micovic.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Same-Day Carotid Artery Stenting and Coronary Artery Bypass Surgery
    (2023)
    Zivkovic, Igor (57192104502)
    ;
    Krasic, Stasa (57192096021)
    ;
    Milacic, Petar (24832086700)
    ;
    Milicic, Miroslav (22934854000)
    ;
    Vukovic, Petar (35584122100)
    ;
    Tabakovic, Zoran (57898013700)
    ;
    Sagic, Dragan (35549772400)
    ;
    Ilijevski, Nenad (57209017323)
    ;
    Petrovic, Ivana (35563660900)
    ;
    Peric, Miodrag (7006618529)
    ;
    Bojic, Milovan (7005865489)
    ;
    Micovic, Slobodan (25929461500)
    Background: The optimal treatment strategy for patients with severe carotid artery disease undergoing coronary artery bypass grafting is still problematic. The important question is whether it is necessary to treat significant carotid disease in patients who have undergone coronary artery bypass grafting. This study ana-lyzed short-and midterm results after same-day carotid artery stenting and coronary artery bypass grafting. Methods: From 2013 to 2020, a total of 69 patients were enrolled in the study. Same-day carotid artery stenting and coronary artery bypass grafting were performed in all patients. The study’s primary end points were the evaluation rate of stroke, myocardial infarction, and death within short-and midterm periods after the procedures. Results: The 30-day mortality was 0%. The occurrences of perioperative adverse events, namely stroke, myocardial infarction, and transient ischemic attack, were 1 (1.4%), 1 (1.4%), and 4 (5.8%), respectively. Mean (IQR) follow-up time was 28 (IQR, 17-43) months. Six (8.8%) patients died during this period. Fatal stroke was registered in 2 cases, and 1 patient experienced a disabling stroke with a fatal outcome. The other 3 patients died because of chronic renal disease, a traffic accident, and for an unknown reason, respectively. Midterm survival in the group was 91.2%. Conclusion: The study showed that same-day carotid artery stenting and coronary artery bypass grafting for concomitant carotid and coronary disease treatment could be a promising and feasible therapeutic strategy. © 2023 by The Texas Heart® Institute, Houston.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Surgical Reconstruction of the Anomalous Left Coronary Artery From the Pulmonary Artery
    (2023)
    Micovic, Slobodan (25929461500)
    ;
    Milacic, Petar (24832086700)
    ;
    Milicic, Miroslav (22934854000)
    ;
    Brkovic, Milica (58091913500)
    ;
    Vukovic, Petar (35584122100)
    ;
    Zivkovic, Igor (57192104502)
    The anomalous left coronary artery from the pulmonary artery is a rare congenital disease. Early surgical reconstruction is mandatory to prevent adverse cardiac events. Direct coronary button transfer, vein graft interposition, ligation, and coronary artery bypass construction are the most commonly used techniques. This case report presents a modified technique of Dacron graft interposition and reimplantation anomalous left coronary artery from the pulmonary artery on the ascending aorta. © 2023 by The Texas Heart® Institute, Houston.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Surgical treatment of a left ventricular pseudoaneurysm with an extracellular matrix patch
    (2024)
    Vukovic, Petar (35584122100)
    ;
    Okiljevic, Bogdan (57193093252)
    ;
    Micovic, Slobodan (25929461500)
    ;
    Zivkovic, Igor (57192104502)
    Left ventricle pseudoaneurysm is a rare and life-threatening complication of myocardial infarction that is formed as a result of left ventricle free wall rupture contained by the overlying pericardium. Urgent surgical repair is crucial, and in most reports, left ventricle was reconstructed with a Dacron or bovine pericardial patch. We present a case of a 66-year-old female with left ventricle pseudoaneurysm which was successfully repaired with an extracellular matrix patch. © Indian Association of Cardiovascular-Thoracic Surgeons 2023.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Surgical treatment of quadruple valve endocarditis in a patient with heart failure
    (2023)
    Milicic, Miroslav (22934854000)
    ;
    Milacic, Petar (24832086700)
    ;
    Vukovic, Petar (35584122100)
    ;
    Nesic, Ivan (57219202239)
    ;
    Tabakovic, Zoran (57898013700)
    ;
    Zivkovic, Igor (57192104502)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Total phalloplasty using a musculocutaneous latissimus dorsi flap
    (2007)
    Perovic, Sava V. (7006446679)
    ;
    Djinovic, Rados (20734254600)
    ;
    Bumbasirevic, Marko (6602742376)
    ;
    Djordjevic, Miroslav (7102319341)
    ;
    Vukovic, Petar (35584122100)
    OBJECTIVE: To present total phalloplasty in children and adults using a musculocutaneous latissimus dorsi (MLD) free flap to create a large neophallus, that allows easy urethroplasty and implantation of a prosthesis. PATIENTS AND METHODS: From April 1999 to January 2006, 16 patients (mean age 24 years, range 10-34) had a total phalloplasty; the indications were congenital anomalies of the penis in 12, iatrogenic in two and accidental penile trauma in two. The MLD flap is mobilized on a subscapular artery and vein, and a thoracodorsal nerve. The neophallus is created on-site and after dividing the neurovascular pedicle, transferred to the pubic region, where it is anastomosed with the femoral artery, saphenous vein and ilio-inguinal nerve. The donor site was closed directly in 15 patients while in one a split-thickness skin graft was used to cover the defect. In the following stages, two- or three-stage buccal mucosa urethroplasty was used in 11 patients; a penile prosthesis was implanted in seven. RESULTS: The mean (range) follow-up was 31 (12-74) months; the penis was 14-18 cm long and 11-15 cm in circumference. There was no partial or total flap necrosis; the donor site healed satisfactorily in 13 patients while in the remaining three there was moderate scarring. The patency of the urethra was good in all patients. Two urethrocutaneous fistulae developed; one closed spontaneously and the other was successfully treated with minor surgery. The function of the implanted penile prostheses was satisfactory in all patients. CONCLUSIONS: The MLD flap allows the creation of a neophallus of good size and with a good aesthetic appearance; it allows urethroplasty and safe implantation of a penile prosthesis, and it can also be used in children. © 2007 The Authors.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback